Study design
The study was conducted in 15 medical wards at 12 hospitals in France and Monaco. For all the hospitals, the study was approved by a French ethics committee (Comité de Protection des Personnes Ouest VI, Brest, France, no. 1279 HPS2) and a Monegasque ethics committee (Comité Consultatif d’Ethique en matière de Recherche Biomédicale, Monaco, no. 2020.8894 AP/jv) and complies with the current revision of the Declaration of Helsinki, the Inter-national Conference on Harmonisation Note for Guidance on Good Clinical Practice and the applicable French and Monegasque regulatory requirements. Written informed consent was obtained from all patients before inclusion. Patients were not involved in the design or planning of this study.